NCT05196061 Human Skin and Gut Mycobiome and Bacteriome Comprehensive Registry
| NCT ID | NCT05196061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospitals Cleveland Medical Center |
| Condition | Healthy Volunteers |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2020-01-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Bacterial and fungal microbiota will be different between individual body sites; however, particular microbiome profiles both whole-body and site-specific will be unique to volunteers with a given parameter such as medical diagnosis, diet, medications taken, geographical area; etc.
Eligibility Criteria
Inclusion Criteria: * Capable of giving informed consent. * Able and willing to complete all required specified study procedures Exclusion Criteria: * Antibiotic or antifungal use whether topical or systemic in the past 2 or 4 weeks, respectively. * Unable and/or unwilling to complete all required study procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05196061 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Volunteers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05196061 currently recruiting?
Yes, NCT05196061 is actively recruiting participants. Contact the research team at mahmoud.ghannoum@uhhospitals.org for enrollment information.
Where is the NCT05196061 trial being conducted?
This trial is being conducted at Cleveland, United States.
Who is sponsoring the NCT05196061 clinical trial?
NCT05196061 is sponsored by University Hospitals Cleveland Medical Center. The trial plans to enroll 5,000 participants.